SEC Tracker
Get the app

Lakewood-Amedex Biotherapeutics LABT

Lakewood-Amedex Biotherapeutics redeemed Series C Preferred Stock

Lakewood-Amedex Biotherapeutics (LABT) filed an 8-K with the SEC on Nov 10, 2026, 5:21 pm ET. Source: the filing on SEC EDGAR.

Item 1.01 Enters material agreement, Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Major
  1. Redeemed 127,097 shares of Series C Preferred Stock for $1.27 million
  2. Redemption price was $10 per share, paid in cash
  3. Shares were returned to treasury, none remain outstanding

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Lakewood-Amedex Biotherapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.